BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2018; 24(28): 3155-3162 [PMID: 30065561 DOI: 10.3748/wjg.v24.i28.3155]
URL: https://www.wjgnet.com/2307-8960/full/v24/i28/3155.htm
Number Citing Articles
1
Shou-Sheng Chu, Yu-Hsuan Kuo, Wen-Shan Liu, Shih-Chang Wang, Chung-Han Ho, Yi-Chen Chen, Ching-Chieh Yang, Hung-Chang Wu. Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81176-w
2
Aminah Jatoi, Fang-Shu Ou, Daniel H. Ahn, Tyler J. Zemla, Jennifer G. Le-Rademacher, Patrick Boland, Kristen K. Ciombor, Nisha L. Jacobs, Boris Pasche, James M. Cleary, Jeannine S. McCune, Katrina S. Pedersen, Afsaneh Barzi, E. Gabriela Chiorean, Erica N. Heying, Heinz-Josef Lenz, Jeff A. Sloan, Axel Grothey, Mario E. Lacouture, Tanios Bekaii-Saab. Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialThe Oncologist 2021; 26(7): 610 doi: 10.1002/onco.13730
3
Xuan Qiu, Manjiang Li, Liqun Wu, Yang Xin, Siyu Mu, Tianxiang Li, Kangjian Song. <p>Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib</p>Cancer Management and Research 2020; : 7983 doi: 10.2147/CMAR.S233448
4
Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Víctor Sapena, Ferran Torres, Neus LLarch, Gemma Iserte, Alejandro Forner, Leonardo da Fonseca, José Ríos, Jordi Bruix, María Reig. Systematic review with meta‐analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenibAlimentary Pharmacology & Therapeutics 2019; 49(5): 482 doi: 10.1111/apt.15088
5
Masanori Ochi, Toshiro Kamoshida, Masahiro Araki, Tadashi Ikegami. Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatmentWorld Journal of Gastroenterology 2021; 27(32): 5424-5437 doi: 10.3748/wjg.v27.i32.5424
6
Yuka Aimono, Noriko Kohyama, Toshiro Kamoshida, Toshinori Yamamoto, Mari Kogo. QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical PracticeYAKUGAKU ZASSHI 2019; 139(11): 1427 doi: 10.1248/yakushi.19-00019